Consumer Driven Health Care

In 2025, hospitals spent nearly $18 billion overturning claims denials alone, with total collection efforts estimated at $43 billion for care already delivered.

More than half of insured patients don't trust that they are paying the lowest available price.

In the United States, Him & Hers now plans to provide GLP-1 customers access to a broad assortment of FDA-approved medications and offer compounded semaglutide through the platform on a limited scale.

The news comes after Amazon announced their agentic health AI system.

The letters, sent Feb. 20 and made public this week, cite false or misleading claims about compounded glucagon-like peptide‑1 medications on company websites.

The new weight management program offers $49 virtual visits, with no subscription required, in 28 states for adults aged 18–64 who plan to pay for GLP-1 medication themselves.